Filing Details
- Accession Number:
- 0001385508-19-000092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-13 16:09:18
- Reporting Period:
- 2019-09-12
- Accepted Time:
- 2019-09-13 16:09:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1385508 | Opiant Pharmaceuticals Inc. | OPNT | Metal Mining (1000) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1551246 | Michael Sinclair | C/O Opiant Pharmaceuticals, Inc. 233 Wilshire Blvd, Suite 280 Santa Monica CA 90401 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-09-12 | 60,000 | $12.52 | 69,220 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $12.50 to $13.54. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.